24.04.2020 Novavax Inc Daily Analysis

24.04.2020 Novavax Inc Daily Analysis

Novavax Inc (NVAX) 20.38usd ,-0.99 ,-4.63% Novavax is trading at  20.83usd and went down with 4.63 percent. Moderna which is a clinical-stage biotechnology company is one of Novavax competitors. The company has announced that it is going to partner with the National Institutes of Health on the development of its Covid-19 vaccine after when Novavax announced that. The White House health advisor Dr.Anthony  said the trial was launched in record speed and their Phase 1 human trial began already in March. The company announced it has received  483 million in federal funding to accelerate the development of their coronavirus vaccine and the stock now it is currently trading on 47.44 USD  and Novavax went down after this announcement with almost 5 percent as traders are looking for great opportunities and weigh every option that comes with any competitor.